voriconazole has been researched along with Allergic Bronchopulmonary Mycosis in 146 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 10 (6.85) | 29.6817 |
2010's | 111 (76.03) | 24.3611 |
2020's | 25 (17.12) | 2.80 |
Authors | Studies |
---|---|
Bocanegra, R; Coalson, JJ; Graybill, JR; McConville, JT; Najvar, LK; Patterson, TF; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO | 1 |
Beauchemin, C; Claveau, D; Dufresne, SF; Guinan, K; Rotstein, C | 1 |
Jorwal, P; Khanna, P; Kodan, P; Ray, A; Sarda, R; Singh, G; Sinha, S; Swain, S; Trikha, A; Vyas, S; Wig, N; Xess, I | 1 |
Bae, NY; Byun, JM; Choe, PG; Kang, CK; Kim, MS; Kim, NJ; Park, KJ; Yoon, SS | 1 |
Chen, W; Goldman, GH; Li, R; Li, Y; Liang, T; Liu, W; Osherov, N; Verweij, PE; Wan, Z; Wang, Q; Zheng, B | 1 |
Eguchi, K; Ishimura, M; Kamei, K; Kibe, Y; Motomura, Y; Ohga, S; Shiraishi, A; Yada, Y | 1 |
Faeli, L; Ghafari, R; Mirzakhani, R; Moslemi, A; Nabati, M; Najafi, N; Salimi, M; Shayesteh Azar, S; Shokohi, T | 1 |
Dobashi, A; Imai, M; Imoto, W; Kakeya, H; Kakuno, S; Mitani, K; Niki, M; Ogawa, M; Shibata, W; Takayama, N; Yamada, K | 1 |
Chiappini, E; Galli, L; Motisi, MA; Pellegrino, R; Taccetti, G; Terlizzi, V | 1 |
Huang, Q; Lu, X; Wu, Y; Xia, L | 1 |
Chastain, DB; Henao-Martínez, AF; Thompson, GR | 1 |
Ao, W; Fu, B; Fu, X; Huang, P; Wang, J | 1 |
Endo, Y; Fujimoto, S; Fujisaki, I; Hosoda, C; Kinoshita, A; Kiritani, A; Kuwano, K; Miyagawa, H; Saito, K; Seki, Y; Takeda, H; Watanabe, N; Yamanaka, Y | 1 |
Azoulay, E; Calvet, L; Darmon, M; De Jong, A; Kerhuel, L; Lemiale, V; Mokart, D; Moreau, AS; Pardo, E; Stoclin, A; Valade, S | 1 |
Cho, SY; Jung, JI; Lee, DG; Lee, KY; Park, YJ; Yi, Y | 1 |
Harada, S; Hayama, B; Kamei, K; Mitani, H; Nakano, K; Ohkushi, D; Yamamoto, Y | 1 |
Brooks, JS; Grant, M; Husson, MA; Khan, SN; Leahy, K; Manur, R | 1 |
Aram, JA; Freivogel, K; Lem, J; Lewis, A; Moosavi, S; Sobel, RE; Younus, M | 1 |
Han, CS; Jia, MY; Zhang, SN | 1 |
Arendrup, MC; Helleberg, M; Steensen, M | 1 |
Bang, JH; Choe, PG; Jun, KI; Kang, CK; Kim, ES; Kim, H; Kim, HB; Kim, NJ; Oh, MD; Park, SW; Park, WB; Shin, DH; Song, KH; Yoo, SJ | 1 |
Bene, P; Dixit, D; Flenaugh, E; Khan, I; Kuete, NT; Oprea-Ilies, G | 1 |
Angarone, M; Flaherty, JD; Mylvaganam, R; Peigh, G; Quaggin-Smith, J; Witting, C | 1 |
Ben-Ami, R; Diego Vélez, J; Grandhi, A; Haider, S; Han, S; Karthaus, M; Klimko, N; Koh, LP; Lee, DG; Maertens, JA; Motyl, MR; Ponce-de-León, A; Raad, I; Rahav, G; Ramírez Sánchez, IC; Sonet, A; Waskin, H; Zhou, J | 1 |
Benoit, P; Ferreira, V; Grandjean Lapierre, S; Halwagi, A; HÉtu, PO; Mathieu, A; Thiboutot, Z | 1 |
Deokar, K; Goel, R; Jain, A; Shadrach, BJ | 1 |
Aguado, JM; Arnaiz, F; Bodro, M; Calvo, J; Cantón, R; Cifrian, JM; Corbella, L; Fariñas, MC; Fernández-Cruz, A; Fernández-Ruiz, M; Filigheddu, E; Fortún, J; Gioia, F; Gonzalez-Rico, C; Linares, L; López-Medrano, F; López-Soria, LM; Machado, M; Martin-Davila, P; Montejo, JM; Moreno, A; Moreno, S; Muñoz, P; Pérez, S; Pérez-Ayala, A; Ras, MM; Rodríguez-Alvarez, RJ; Sabe, N; Torre-Cisneros, J; Valerio, M; Vidal, E | 1 |
Chandrasekar, P; Pasula, S | 1 |
Ito, S; Machida, H; Miyairi, I; Tetsuka, N; Yaguchi, T | 1 |
Albert, ND; Heo, ST; Jiang, Y; Jiménez-Ortigosa, C; Kontoyiannis, DP; Lewis, RE; Meis, JF; Mikos, AG; Perlin, DS; Tarrand, J; Tatara, AM; Tverdek, F; Verweij, PE | 1 |
Birch, M; Buil, JB; Law, D; Meis, JF; Melchers, WJG; Rijs, AJMM; Verweij, PE | 1 |
Blot, S; Bulpa, P; Dimopoulos, G; Gomes, A; Meersseman, W; Mergulhão, P; Misset, B; Paiva, JA; Rello, J; Taccone, FS; Van den Abeele, AM; Vogelaers, D | 1 |
Bader, O; Baretton, G; Buchheidt, D; Geibel, S; Groß, U; Jacobs, E; Ostrosky-Zeichner, L; Rößler, S; Sommer, U; Spiess, B; Stölzel, F | 1 |
Kim, SH; Park, SY; Yoon, JA | 1 |
Box, H; Colombo, AL; Hope, WW; Johnson, A; Kolamunnage-Dona, R; Livermore, J; McEntee, L; Negri, CE; Ramos-Martín, V; Schwartz, JA; Whalley, S | 1 |
Chen, J; Hu, J; Liu, X; Su, H; Tong, J; Xiao, L; Yang, H; Zhang, L | 1 |
Hoenigl, M; Krause, R; Neumeister, P; Prattes, J; Wölfler, A | 1 |
Goldraich, L; Husain, S; Kabbani, D; Ross, H; Rotstein, C | 1 |
Cabanes, L; Martinez Moragón, E; Plaza, P | 1 |
Cornely, OA; Croos-Dabrera, R; Engelhardt, M; Hope, W; Kontoyiannis, DP; Lademacher, C; Lortholary, O; Mullane, K; Patterson, TF; Selleslag, D | 1 |
Murar, AK; Ojha, UC; Pal, RS; Spalgais, S | 1 |
Chen, J; Chen, Y; Gao, J; He, Q; Hou, J; Li, Y; Liu, S; Qi, T; Wen, W; Wu, Y; Yu, R; Zhang, Q; Zhou, F; Zhu, C | 1 |
Fujioka, N; Iijima, Y; Kakizaki, Y; Kobayashi, Y; Miyashita, Y; Tsutsui, T; Uchida, Y | 1 |
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
Ishiguro, T; Kagiyama, N; Kojima, A; Kurashima, K; Nakamoto, Y; Shimizu, Y; Takaku, Y; Takayanagi, N; Yamada, M | 1 |
Ashworth, A; Barker, J; Felton, TW; Foden, P; Geraghty, CG; Muldoon, EG; Richardson, MD; Rodriguez-Goncer, I; Thomas, S | 1 |
Belderbos, S; Brock, M; Hillen, A; Himmelreich, U; Holvoet, B; Lagrou, K; Maertens, J; Poelmans, J; Vande Velde, G; Vanherp, L; Zhai, L | 1 |
Alanio, A; Bretagne, S; Catherinot, E; Garcia-Hermoso, D; Jullien, V; Lortholary, O; Pilmis, B; Scemla, A | 1 |
Landsberg, D; Leung, M; Poinen, K; Wright, AJ | 1 |
Chen, L; Dong, H; Dong, Y; Lei, J; Li, Y; Meng, T; Wang, T; Yang, Q; Zhang, T | 1 |
Chakrabarti, A; Kaur, H; Rudramurthy, SM; Singh, M; Singh, S | 1 |
Chaftari, AM; Dandachi, D; Fernández-Cruz, A; Hachem, R; Jiang, Y; Raad, I; Wilson Dib, R | 1 |
Bentvelsen, RG; de Haan, AF; Kuiper, EJ; Lestrade, PP; Melchers, WJG; Rijnders, BJA; Schalekamp, S; Schauwvlieghe, AFAD; van der Beek, MT; van der Hoeven, HL; van der Hoven, B; van der Lee, HA; van der Velden, WJFM; van Paassen, J; Verweij, PE | 1 |
Foerster, KI; Mahmoudi, M; Mikus, G; Seeßle, J; Vay, M | 1 |
Aït-Ammar, N; Botterel, F; Dannaoui, E; Foulet, F; Imbert, S; Levesque, E; Murat, JB | 1 |
Chaftari, AM; Dib, RW; Ghaly, F; Hachem, RY; Jiang, Y; Raad, I | 1 |
Brüggemann, RJ; Hanff, LM; Henriet, S; Koch, BCP; Lempers, VJ; Mavinkurve-Groothuis, AM; Meuwese, E; van der Sluis, IM; Warris, A | 1 |
Begic, E; Cickusic, A; Halilovic, MA; Karasalihovic, Z; Mujkanovic, A; Nislic, E; Trnacevic, A; Trnacevic, S | 1 |
Araki, K; Fujimoto, K; Kamei, K; Konishi, M; Maeshima, A; Oshima, H; Oyamada, Y; Tsukamoto, M; Ushikubo, M; Yagi, K | 1 |
Hakkouni, AE; Mansouri, N | 1 |
Lu, X; Moon, C; Su, Y; Watts, AB; Williams, RO | 1 |
Aram, JA; Chen, X; Jin, J; Liu, Y; Lou, YJ; Meng, H; Pan, S; Patterson, TF; Schwartz, IS; Wu, D; Yan, JL; Zhang, X | 1 |
Fukuda, Y; Hamano, Y; Iizuka, H; Inano, T; Izumi, H; Nakamura, N; Noguchi, M; Okubo, M; Sakajiri, S; Sawada, T; Sekiguchi, Y; Sugimoto, K; Takizawa, H; Tomita, S; Wakabayashi, M | 1 |
Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL | 1 |
Hu, LF; Lin, GY; Liu, YJ; Pan, XF; Shi, DW; Xu, RA; Ye, XL; Zhang, CH; Zhang, XH | 1 |
Agarwal, K; Chowdhary, A; Gaur, SN; Kathuria, S; Meis, JF; Randhawa, HS; Roy, P; Singh, PK | 1 |
da Trindade, MC; de Menezes, AI; de Souza, DW; Dos Santos, VM; Nascimento, AL; Oguma, PM | 1 |
Bobek-Billewicz, B; Foroncewicz, B; Jarząb, B; Krawczyk, M; Mucha, K; Orłowski, T; Pączek, L; Raczyńska, J; Religioni, J | 1 |
Amat, P; Benet, I; Bravo, D; Clari, MÁ; Costa, E; Giménez, E; Muñoz-Cobo, B; Navarro, D; Nieto, J; Remigia, MJ; Solano, C | 1 |
Chen, J; Huang, J; Li, L; Yang, Q | 1 |
Clements, RM; Estrada, L; Jon, CK; Mosquera, RA | 1 |
Lo, CH; Wu, SW | 1 |
Blot, SI; Charles, PE; Dimopoulos, G; Martin, C; Meersseman, W; Pérez, M; Rao, R; Rello, J; Spapen, H; Spapen, J; Taccone, FS; Vogelaers, D | 1 |
Sun, H; Zhuo, J | 1 |
Annaert, P; de Loor, H; Lagrou, K; Maertens, J; Spriet, I; Vanstraelen, K; Vercammen, I; Wauters, J | 1 |
Han, X; Huang, G; Li, W; Liu, Q; Meng, M; Ni, X; Wang, J; Wei, Z; Yang, X; Ye, X; Zheng, A | 1 |
Donnelly, JP; Herbrecht, R; Johnson, EM; Maertens, J; Marchetti, O; Pappas, PG; Patterson, TF; Schlamm, HT; Slavin, MA | 1 |
Hachem, R; Helou, GE; Jiang, Y; Kontoyiannis, DP; Raad, II; Zakhem, AE | 1 |
Cheng, Y; Mu, X; Nie, L; Wang, G; Yu, J | 1 |
Choi, SH; Hong, HL; Jung, J; Kim, SH; Kim, YS; Lee, SO; Woo, JH | 1 |
Hu, F; Lin, H; Lu, K; Shen, C; Song, X; Tan, M; Wang, C; Xie, S; Xu, L; Yuan, Q; Zhang, Y | 1 |
Marr, K; Ostrander, D; Shoham, S | 1 |
Arav-Boger, R; Dabb, A; Hsu, AJ | 1 |
Chiu, I; Fuller, J; Remington, TL | 1 |
Costagliola, D; de Castro, N; Denis, B; Guiguet, M; Lortholary, O; Mechaï, F; Melica, G; Revest, M | 1 |
Shah, M; Singhal, P | 1 |
Ahn, KS; Hwang, JS; Jang, BK; Kang, KJ; Kang, YN; Kim, HT; Kim, IM; Kim, TS; Kim, YH | 1 |
Borobia, AM; Carcas-Sansuán, A; Cendejas-Bueno, E; Escosa-García, L; García-Rodriguez, J; Gomez-Lopez, A; Plaza, D; Río-García, M | 1 |
Gonzalez, BE; Gordon, SM; Hanna, R; Hicks, JK; Kusick, K; Murthy, S; Raja, S; Zembillas, AS | 1 |
Cho, SY; Choi, JH; Choi, JK; Choi, SM; Kim, SB; Kim, SH; Lee, DG; Lee, HJ; Lee, JW; Park, SH; Yoo, JH | 1 |
Chandrasekar, PH; Levine, MT | 1 |
Bouza, E; Escribano, P; Guinea, J; Montilla, P; Muñoz, P; Padilla, B | 1 |
Buscemi, C; Corrao, S; Imburgia, C | 1 |
Marzani, FC; Mojoli, F; Tavazzi, G; Via, G | 1 |
Chen, L; Dong, Y; Lei, J; Li, Y; Meng, T; Wang, T; Wang, Y; Xing, J; Yang, Q; Zhang, T | 1 |
Barac, A; Dudvarski-Ilic, A; Rubino, S; Stevanovic, G; Vukicevic, TA; Zugic, V | 1 |
Bakker-Woudenberg, IA; Mathot, RA; Rijnders, BJ; Tavakol, M; ten Kate, MT; van de Sande, WW; van Vianen, W | 1 |
Chemaissani, A; Ernestus, K; Kamp, M; Knüttgen, D; Matten, J; Sakka, SG; Ströhlein, M; Wappler, F | 1 |
Bosselmann, S; Coalson, JJ; Nelson, NA; Peters, JI; Tolman, JA; Wiederhold, NP; Williams, RO | 1 |
Baert, K; Beernaert, LA; Chiers, K; Haesebrouck, F; Martel, A; Pasmans, F; Van Waeyenberghe, L | 1 |
Eberhardt, R; Ebinger, D; Eckerle, I; Eisenbach, C; Gotthardt, D; Junghanss, T; Schnabel, PA; Stremmel, W | 1 |
Ader, F; Bienvenu, AL; Nseir, S; Rammaert, B | 1 |
Karaahmet, T; Korten, V; Odabasi, Z; Tigen, E; Tigen, K | 1 |
Hirano, T; Imai, K; Kagawa, K; Kasai, M; Kiyama, Y; Kobayashi, K; Kobayashi, N; Miyazono, T; Ogasawara, M; Tanimoto, M | 1 |
Gómez-Bueno, M; Lázaro, MT; Pulpón, L; Ramos, A; Salas, C; Sanchez, I; Segovia, J | 1 |
Meletiadis, J; Pournaras, S; Roilides, E; Walsh, TJ | 1 |
Alvarez, M; Attal, M; Cassaing, S; Chabrol, A; Cuzin, L; Giron, J; Huguet, F; Linas, MD; Récher, C; Tetu, L; Verdeil, X | 1 |
Begué, D; Billaud, E; Boussaud, V; Caruba, T; Guillemain, R; Korb, V; Prognon, P; Sabatier, B; Thomas, A | 1 |
Akashi, K; Aoki, T; Harada, N; Iwasaki, H; Kamezaki, K; Miyamoto, T; Mori, Y; Nagafuji, K; Shimono, N; Takenaka, K; Teshima, T; Yamauchi, T; Yoshimoto, G | 1 |
Jensen, SG; Nielsen, TL | 1 |
Kim, A; Kuti, JL; Nicolau, DP | 1 |
Clancy, CJ; Cline, C; Jantz, MA; Kulkarni, V; Leather, H; Nguyen, MH; Wheat, LJ; Wingard, JR | 1 |
Deeren, D | 1 |
Chai, LY; Hsu, LY | 1 |
Ahmad, S; Chandra, J; Chowdhary, A; Kathuria, S; Khan, ZU; Khanna, G; Randhawa, HS; Roy, P; Singh, V | 1 |
Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
Karthaus, M | 1 |
Maschmeyer, G; Sandherr, M | 1 |
Clemons, KV; Schwartz, JA; Stevens, DA | 1 |
Bhagwat, K; Brooks, M; Eisen, D; Royse, A; Royse, C; Sparks, P | 1 |
Ko, WC; Lee, HC; Lo, HJ; Wu, CJ | 1 |
Choi, SM; Kang, MK; Kim, HJ; Kim, SH; Kwon, JC; Lee, DG; Min, WS | 1 |
Akalin, H; Dizdar, OS; Ener, B; Ersoy, A; Koc, AO | 1 |
Beiras-Fernandez, A; Bigdeli, AK; Kaczmarek, I; Michel, S; Nickel, T; Reichart, B; Ueberfuhr, P | 1 |
Chang, TC; Hsiue, HC; Hsiue, YC; Hsueh, PR; Huang, YT; Lee, PI; Wu, TH | 1 |
Choi, SH; Hong, SB; Kim, MN; Kim, SH; Kim, YS; Koh, Y; Lee, SO; Lim, CM; Woo, JH | 1 |
Falcone, M; Mancini, C; Morelli, A; Russo, A; Vena, A; Venditti, C; Venditti, M | 1 |
Rocha, L; Saleiro, S | 1 |
Wintenberger, C | 1 |
Briegel, J; Chouker, A; Frey, L; Kaufmann, I; Mayr, D; Spiekermann, K; Thiel, M; van der Heide, V | 1 |
Bocanegra, R; Kirkpatrick, WR; Kugler, AR; Najvar, LK; Patterson, TF; Perkins, K; Pfeiffer, J; Sweeney, TD; Vallor, AC; Wiederhold, NP | 1 |
Benjamin, DK; Blaschke, AJ; Cohen-Wolkowiez, M; Doby, EH; Driscoll, TA; Martin, PL; Moran, C; Pavia, AT; Ward, RM | 1 |
Babor, F; Borkhardt, A; Janßen, G; Laws, HJ; Mackenzie, C; Meisel, R; Sabir, H; Schaper, J; Schuster, F; Siepermann, M; Wessalowski, R | 1 |
Egerer, G | 1 |
Baghaei, P; Droudinia, A; Javanmard, P; Mansouri, D; Marjani, M; Najafizadeh, K; Sarrafzadeh, SA; Soraghi, A; Tabarsi, P; Zandian, P | 1 |
Al-Nakeeb, Z; Arendrup, MC; Cuenca-Estrella, M; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Lass-Flörl, C; Majithiya, JB; Warn, PA | 1 |
Choi, SH; Chun, S; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, KH; Lee, SO; Lee, YJ; Woo, JH | 1 |
Al-Nakeeb, Z; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Warn, PA | 1 |
Beltran, C; Bourge, RC; Bourke, P; Castro, P; Rabagliati, R; Verdejo, H; Winter, JL | 1 |
Atalay, MA; Koç, N; Sav, H; Unal, E | 1 |
Li, L; Ling, Z; Shao, F; Sheng, J; Wu, Z | 1 |
Abdulaziz, S; Al Jahdali, H; Baharoon, S | 1 |
Arabia, FA; Blair, JE; Kusne, S; Scott, RL; Steidley, DE; Vikram, HR; Webb, BJ | 1 |
Li, R; Mu, X; Yu, J | 1 |
Shi, Y; Sun, HM; Xu, XY; Zhao, BL | 1 |
11 review(s) available for voriconazole and Allergic Bronchopulmonary Mycosis
Article | Year |
---|---|
Management of pulmonary aspergillosis in children: a systematic review.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Mannans; Pulmonary Aspergillosis; Sensitivity and Specificity; Voriconazole | 2023 |
Voriconazole-refractory invasive aspergillosis.
Topics: Antifungal Agents; Aspergillus; Biopsy; Coinfection; Cytochrome P-450 CYP2C19; Diagnosis, Differential; Diagnostic Errors; Drug Monitoring; Drug Resistance, Fungal; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pharmacogenetics; Pharmacogenomic Variants; Predictive Value of Tests; Tomography, X-Ray Computed; Voriconazole | 2017 |
Invasive pulmonary aspergillosis due to Aspergillus lentulus in an adult patient: A case report and literature review.
Topics: Aged, 80 and over; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antifungal Agents; Aspergillus; Bronchoscopy; Fatal Outcome; Female; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lung; Tomography, X-Ray Computed; Voriconazole | 2019 |
Cryptogenic organizing pneumonia associated with invasive pulmonary aspergillosis: a case report and review of the literature.
Topics: Adrenal Cortex Hormones; Antifungal Agents; Cryptogenic Organizing Pneumonia; Fatal Outcome; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Voriconazole | 2014 |
Adverse effects of voriconazole: Over a decade of use.
Topics: Adult; Alopecia; Antifungal Agents; Arrhythmias, Cardiac; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Monitoring; Head and Neck Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Nail Diseases; Nervous System Diseases; Periostitis; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck; Voriconazole | 2016 |
Invasive Aspergillus fumigatus infection after Plasmodium falciparum malaria in an immuno-competent host: case report and review of literature.
Topics: Antifungal Agents; Aspergillus fumigatus; Caspofungin; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Malaria, Falciparum; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2009 |
Management of invasive aspergillosis in patients with COPD: rational use of voriconazole.
Topics: Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Recent advances in invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Biomarkers; Galactose; Humans; Invasive Pulmonary Aspergillosis; Lectins, C-Type; Mannans; Membrane Proteins; Nerve Tissue Proteins; Polymorphism, Genetic; Pyrimidines; Toll-Like Receptor 4; Triazoles; Voriconazole | 2011 |
Prophylaxis and treatment of invasive aspergillosis with voriconazole, posaconazole and caspofungin: review of the literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Clinical Trials as Topic; Drug Therapy, Combination; Echinocandins; Evidence-Based Medicine; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2011 |
Pharmacology and metabolism of voriconazole and Posaconazole in the treatment of invasive aspergillosis: review of the literature.
Topics: Antifungal Agents; Drug Interactions; Humans; Invasive Pulmonary Aspergillosis; Pyrimidines; Triazoles; Voriconazole | 2011 |
Diagnosis of airway-invasive pulmonary aspergillosis by tree-in-bud sign in an immunocompetent patient: case report and literature review.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchiolitis; Bronchoscopy; Caspofungin; Diagnosis, Differential; Drug Therapy, Combination; Echinocandins; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Lung; Male; Pyrimidines; Sputum; Tomography, X-Ray Computed; Triazoles; Tuberculosis, Pulmonary; Voriconazole; Young Adult | 2013 |
6 trial(s) available for voriconazole and Allergic Bronchopulmonary Mycosis
Article | Year |
---|---|
Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Antifungal Agents; Double-Blind Method; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Triazoles; Voriconazole; Young Adult | 2021 |
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial.
Topics: Adult; Aged; Antifungal Agents; Aspergillus; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neutropenia; Nitriles; Pyridines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
Topics: Adult; Anidulafungin; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Karnofsky Performance Status; Lung; Male; Mannans; Middle Aged; Platelet Count; Prospective Studies; Tomography, X-Ray Computed; Voriconazole | 2019 |
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2019 |
Application of the 2008 definitions for invasive fungal diseases to the trial comparing voriconazole versus amphotericin B for therapy of invasive aspergillosis: a collaborative study of the Mycoses Study Group (MSG 05) and the European Organization for R
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2015 |
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
129 other study(ies) available for voriconazole and Allergic Bronchopulmonary Mycosis
Article | Year |
---|---|
Inhaled voriconazole for prevention of invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Invasive Pulmonary Aspergillosis; Mice; Mice, Inbred ICR; Pyrimidines; Triazoles; Voriconazole | 2009 |
Economic evaluation of isavuconazole for suspected invasive pulmonary aspergillosis in Canada.
Topics: Antifungal Agents; Aspergillosis; Canada; Cost-Benefit Analysis; Humans; Invasive Pulmonary Aspergillosis; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
COVID-19-associated subacute invasive pulmonary aspergillosis.
Topics: Adult; Antibodies, Fungal; Aspergillus; COVID-19; Humans; Immunoglobulin G; Invasive Pulmonary Aspergillosis; Middle Aged; Voriconazole | 2022 |
Successful treatment of angioinvasive aspergillosis causing diaphragmatic rupture with bowel perforation and cerebral aspergillosis in a patient with FLT3-mutated acute myeloid leukemia: A case report.
Topics: Adult; Antifungal Agents; fms-Like Tyrosine Kinase 3; Humans; Intestinal Perforation; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Micafungin; Pyrimidines; Thoracic Injuries; Triazoles; Voriconazole | 2022 |
Triazole-resistant
Topics: Antifungal Agents; Aspergillus; Aspergillus fumigatus; China; Drug Resistance, Fungal; Fermentation; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2022 |
Post-transplant Schizophyllum commune abscess in a pediatric patient with chronic granulomatous disease.
Topics: Abscess; Child; Granulomatous Disease, Chronic; Humans; Invasive Pulmonary Aspergillosis; Male; Schizophyllum; Voriconazole | 2023 |
Post-COVID-19 fatal Aspergillus endocarditis: A case report.
Topics: Aspergillus; COVID-19; Endocarditis; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Voriconazole | 2023 |
Characterization of Aspergillus spp. isolated from patients with coronavirus disease 2019.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; COVID-19; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Voriconazole | 2023 |
Case report: nanopore targeted sequencing in the diagnosis of invasive pulmonary Aspergillus infection in a patient with acute promyelocytic leukemia.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Promyelocytic, Acute; Nanopores; Quality of Life; Voriconazole | 2023 |
Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Voriconazole | 2023 |
Fatal invasive pulmonary aspergillosis in non-immunocompromised host: A case report.
Topics: Adult; Antifungal Agents; Aspergillosis; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Voriconazole | 2023 |
A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient.
Topics: Antifungal Agents; Aspergillus fumigatus; Biopsy; Bronchoalveolar Lavage Fluid; Bronchoscopy; Diabetes Mellitus, Type 1; Diabetic Ketoacidosis; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Invasive Pulmonary Aspergillosis; Male; Micafungin; Middle Aged; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2020 |
Invasive pulmonary aspergillosis in critically ill patients with hematological malignancies.
Topics: Adult; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mortality; Retrospective Studies; Survival Rate; Voriconazole | 2019 |
Invasive Pulmonary Aspergillosis Due to Aspergillus awamori: Role of Calcium Oxalate Crystal Precipitation Mimicking Mucormycosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Biomarkers; Burkitt Lymphoma; Calcium Oxalate; Diagnosis, Differential; Genes, Fungal; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Middle Aged; Mucormycosis; Voriconazole | 2020 |
Fatal invasive pulmonary aspergillosis caused by voriconazole-resistant Aspergillus tubingensis in a patient with solid tumor.
Topics: Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Fatal Outcome; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Middle Aged; Tongue Neoplasms; Voriconazole | 2020 |
Invasive pseudomembranous upper airway and tracheal Aspergillosis refractory to systemic antifungal therapy and serial surgical debridement in an Immunocompetent patient.
Topics: Adult; Antifungal Agents; Aspergillus fumigatus; Combined Modality Therapy; Debridement; Drug Resistance, Fungal; Endoscopy; Female; Humans; Invasive Pulmonary Aspergillosis; Nasopharynx; Trachea; Treatment Outcome; Voriconazole | 2020 |
Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned from a Healthcare Professional Survey.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Checklist; Chemical and Drug Induced Liver Injury; Cross-Sectional Studies; Dermatitis, Phototoxic; Drug-Related Side Effects and Adverse Reactions; European Union; Health Care Surveys; Health Personnel; Humans; Invasive Pulmonary Aspergillosis; Mycoses; Pamphlets; Pharmacovigilance; Risk Reduction Behavior; Self Report; Skin Neoplasms; Voriconazole | 2019 |
Integrated Chinese and Western Medicines Shorten Treatment Course of Subacute Invasive Pulmonary Aspergillosis: A Case Report.
Topics: Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Male; Medicine, Chinese Traditional; Middle Aged; Voriconazole | 2020 |
Invasive aspergillosis in patients with severe COVID-19 pneumonia.
Topics: Antifungal Agents; COVID-19; Denmark; Extracorporeal Membrane Oxygenation; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Respiratory Distress Syndrome; SARS-CoV-2; Voriconazole | 2021 |
Short course of voriconazole therapy as a risk factor for relapse of invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Drug Administration Schedule; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Recurrence; Republic of Korea; Retrospective Studies; Risk Factors; Time Factors; Tomography, X-Ray Computed; Voriconazole | 2020 |
Invasive Pulmonary Aspergillosis with Hydropneumothorax in a Patient Taking High-Dose Glucocorticoids.
Topics: Aged; Antifungal Agents; Female; Glucocorticoids; Humans; Hydropneumothorax; Invasive Pulmonary Aspergillosis; Voriconazole | 2020 |
Invasive pulmonary aspergillosis after treatment with tocilizumab in a patient with COVID-19 ARDS: a case report.
Topics: Aged; Antibodies, Monoclonal, Humanized; Antiviral Agents; Aspergillus; COVID-19 Drug Treatment; Humans; Immunomodulation; Invasive Pulmonary Aspergillosis; Male; Micafungin; Opportunistic Infections; Receptors, Interleukin-6; SARS-CoV-2; Voriconazole | 2021 |
Voriconazole Sequestration During Extracorporeal Membrane Oxygenation for Invasive Lung Aspergillosis: A Case Report.
Topics: Antifungal Agents; Aspergillosis; Extracorporeal Membrane Oxygenation; Humans; Invasive Pulmonary Aspergillosis; Voriconazole | 2022 |
Invasive pulmonary aspergillosis in a COVID-19 recovered patient: unravelling an infective sequalae of the SARS-CoV-2 virus.
Topics: Antifungal Agents; Coinfection; COVID-19; Critical Care; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Obesity, Morbid; SARS-CoV-2; Treatment Outcome; Voriconazole | 2021 |
Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study).
Topics: Adult; Antifungal Agents; Causality; Cohort Studies; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Organ Transplantation; Retrospective Studies; Sensitivity and Specificity; Spain; Voriconazole; Young Adult | 2021 |
Spontaneous Hemoptysis in a Patient With COVID-19.
Topics: Aged; Antifungal Agents; Aspergillus niger; Clinical Deterioration; COVID-19; Critical Illness; Critical Pathways; Diagnosis, Differential; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Lung; Male; Pseudomonas aeruginosa; Radiography, Thoracic; Respiration, Artificial; SARS-CoV-2; Superinfection; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2021 |
Invasive pulmonary aspergillosis due to azole-resistant Aspergillus lentulus.
Topics: Antifungal Agents; Aspergillus; Child; Drug Resistance, Fungal; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Voriconazole | 2017 |
Changes in In Vitro Susceptibility Patterns of Aspergillus to Triazoles and Correlation With Aspergillosis Outcome in a Tertiary Care Cancer Center, 1999-2015.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus fumigatus; Cohort Studies; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Ergosterol; Female; Fungal Proteins; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Polymorphism, Genetic; Prospective Studies; Tertiary Healthcare; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
In vitro activity of the novel antifungal compound F901318 against difficult-to-treat Aspergillus isolates.
Topics: Acetamides; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Genotype; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Nitriles; Piperazines; Point Mutation; Pyridines; Pyrimidines; Pyrroles; Triazoles; Voriconazole | 2017 |
Drivers and impact of antifungal therapy in critically ill patients with Aspergillus-positive respiratory tract cultures.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus; Clinical Decision-Making; Critical Illness; Delayed Diagnosis; Drug Therapy, Combination; Echinocandins; Female; Fungal Proteins; Humans; Intensive Care Units; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prognosis; Respiratory System; Treatment Outcome; Voriconazole | 2017 |
Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a
Topics: Aged; Alleles; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Azoles; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Multiple, Fungal; Echinocandins; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Male; Microbial Sensitivity Tests; Mutation; Treatment Outcome; Triazoles; Voriconazole | 2017 |
Pharmacodynamics of the Novel Antifungal Agent F901318 for Acute Sinopulmonary Aspergillosis Caused by Aspergillus flavus.
Topics: Acetamides; Animals; Antifungal Agents; Aspergillus flavus; Cells, Cultured; Dose-Response Relationship, Drug; Humans; Invasive Pulmonary Aspergillosis; Mice; Piperazines; Pyrimidines; Pyrroles; Triazoles; Voriconazole | 2018 |
Significance of monitoring plasma concentration of voriconazole in a patient with liver failure: A case report.
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Drug Monitoring; Humans; Invasive Pulmonary Aspergillosis; Liver Failure; Male; Treatment Outcome; Voriconazole; Young Adult | 2017 |
Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: An illustrative case study.
Topics: Amphotericin B; Anemia, Aplastic; Antifungal Agents; Aspergillus; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Male; Neutropenia; Nitriles; Pyridines; Transaminases; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2018 |
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Asymptomatic Diseases; Cohort Studies; Disease Outbreaks; Echinocandins; Female; Galactose; Heart Transplantation; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Mass Screening; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplant Recipients; Voriconazole | 2018 |
Chronic necrotizing pulmonary aspergillosis in an immunocompetent patient.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Bronchoscopy; Female; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Voriconazole | 2018 |
Invasive Aspergillus Pseudomembranous and Obstructive Tracheo-bronchitis in an Immuno-competent Patient.
Topics: Airway Obstruction; Antifungal Agents; Aspergillus; Bronchitis; Bronchoscopy; Female; Galactose; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Mannans; Sputum; Tracheitis; Treatment Outcome; Voriconazole; Young Adult | 2017 |
Improving survival of acute-on-chronic liver failure patients complicated with invasive pulmonary aspergillosis.
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Aged, 80 and over; Antifungal Agents; Biomarkers; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prognosis; Severity of Illness Index; Survival Rate; Tomography, X-Ray Computed; Voriconazole; Young Adult | 2018 |
Invasive pulmonary aspergillosis mimicking organizing pneumonia after mTOR inhibitor therapy: A case report.
Topics: Aged; Aspergillus; Carcinoma, Renal Cell; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Pneumonia; Sirolimus; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Treatment Outcome; Voriconazole | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Allergic Bronchopulmonary Mycosis Due to Schizophyllum commune Treated Effectively with Voriconazole.
Topics: Antifungal Agents; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Schizophyllum; Sputum; Voriconazole | 2018 |
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Immunocompromised Host; Influenza, Human; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult | 2018 |
A Multimodal Imaging Approach Enables
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Disease Models, Animal; Disease Progression; Invasive Pulmonary Aspergillosis; Leukopenia; Luminescent Measurements; Lung; Magnetic Resonance Imaging; Male; Mice; Mice, Inbred BALB C; Multimodal Imaging; Treatment Outcome; Voriconazole | 2018 |
Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Fungal Proteins; Humans; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Mutation; Prognosis; Voriconazole | 2018 |
A vexing case of bone pain in a renal transplant recipient: Voriconazole-induced periostitis.
Topics: Antifungal Agents; Drug Substitution; Graft Rejection; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Middle Aged; Periostitis; Transplant Recipients; Triazoles; Voriconazole | 2018 |
A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model.
Topics: A549 Cells; Aspergillus fumigatus; Biomarkers; Computer Simulation; Dose-Response Relationship, Drug; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Monte Carlo Method; Regression Analysis; Voriconazole | 2018 |
Aspergillus terreus Causing Probable Invasive Aspergillosis in a Patient with Cystic Fibrosis.
Topics: Antifungal Agents; Aspergillus; Child; Cystic Fibrosis; Drug Monitoring; Galactose; Humans; India; Invasive Pulmonary Aspergillosis; Male; Mannans; Treatment Outcome; Voriconazole | 2019 |
Invasive pulmonary aspergillosis in patients with solid tumours: risk factors and predictors of clinical outcomes.
Topics: Aged; Antifungal Agents; Aspergillus; Female; Follow-Up Studies; Humans; Immunocompromised Host; Incidence; Invasive Pulmonary Aspergillosis; Lung; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies; Risk Factors; Survival Analysis; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2018 |
Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Autoimmune Diseases; Child; Child, Preschool; Drug Resistance, Fungal; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Survival Analysis; Time Factors; Voriconazole | 2019 |
No alteration of voriconazole concentration by plasmapheresis in a critically ill patient.
Topics: Aged; Antifungal Agents; Critical Illness; Female; Granulomatosis with Polyangiitis; Humans; Invasive Pulmonary Aspergillosis; Plasmapheresis; Voriconazole | 2019 |
Aspergillus pseudodeflectus: a new human pathogen in liver transplant patients.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Liver; Liver Transplantation; Microbial Sensitivity Tests; Middle Aged; Transplant Recipients; Voriconazole | 2018 |
Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Empiricism; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Precision Medicine; Prognosis; Retrospective Studies; Standard of Care; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Impact of dose adaptations following voriconazole therapeutic drug monitoring in pediatric patients.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Infant; Infant, Newborn; Invasive Pulmonary Aspergillosis; Male; Retrospective Studies; Serum; Voriconazole | 2019 |
Invasive Aspergillosis After Kidney Transplant-Treatment Approach.
Topics: Adult; Antifungal Agents; Caspofungin; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Male; Plasmapheresis; Pneumonectomy; Postoperative Complications; Tacrolimus; Treatment Outcome; Voriconazole | 2018 |
[Invasive pulmonary aspergillosis in a patient with human immunodeficiency virus (HIV)].
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; HIV Infections; Humans; Invasive Pulmonary Aspergillosis; Male; Tomography, X-Ray Computed; Voriconazole | 2018 |
Enhanced Aerosolization of High Potency Nanoaggregates of Voriconazole by Dry Powder Inhalation.
Topics: Administration, Inhalation; Aerosols; Antifungal Agents; Crystallization; Drug Compounding; Drug Design; Drug Liberation; Drug Stability; Dry Powder Inhalers; Excipients; Feasibility Studies; Humans; Invasive Pulmonary Aspergillosis; Mannitol; Particle Size; Powders; Voriconazole | 2019 |
A Case of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia with Aspergillus Brain Abscess and Invasive Pulmonary Aspergillosis Successfully Treated with Voriconazole Followed by Cord Blood Transplantation.
Topics: Antifungal Agents; Brain Abscess; Cord Blood Stem Cell Transplantation; Female; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole | 2019 |
Successful management of voriconazole-associated hyponatremia with therapeutic drug monitoring.
Topics: Aged; Antifungal Agents; Aspergillus fumigatus; Drug Monitoring; Humans; Hyponatremia; Invasive Pulmonary Aspergillosis; Male; Pulmonary Disease, Chronic Obstructive; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Molecular characterization and in vitro antifungal susceptibility profile of Schizophyllum commune, an emerging basidiomycete in bronchopulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Pyrimidines; Schizophyllum; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |
A 76-year-old man with a right lung adenocarcinoma and invasive Aspergillosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged; Antifungal Agents; Aspergillus fumigatus; Histocytochemistry; Humans; Invasive Pulmonary Aspergillosis; Lung; Lung Neoplasms; Male; Microscopy; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Positron-Emission Tomography; Pyrimidines; Triazoles; Voriconazole | 2013 |
Atypical presentation of invasive pulmonary aspergillosis in a liver transplant recipient.
Topics: Adolescent; Antifungal Agents; Hepatoblastoma; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Liver Neoplasms; Liver Transplantation; Male; Opportunistic Infections; Pyrimidines; Solitary Pulmonary Nodule; Time Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2013 |
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Echinocandins; Female; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Phosphoproteins; Pyrimidines; Retrospective Studies; Stem Cell Transplantation; Superinfection; Transplantation, Homologous; Triazoles; Viral Matrix Proteins; Voriconazole; Young Adult | 2014 |
Risk factors for invasive pulmonary aspergillosis and hospital mortality in acute-on-chronic liver failure patients: a retrospective-cohort study.
Topics: Adult; Antifungal Agents; Cross Infection; End Stage Liver Disease; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Rate; Triazoles; Voriconazole | 2013 |
Early diagnosis and treatment of invasive pulmonary aspergillosis in a patient with cystic fibrosis.
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Bronchoalveolar Lavage; Child; Cystic Fibrosis; Early Diagnosis; Fatal Outcome; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole | 2013 |
Chronic necrotizing pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Tomography, X-Ray Computed; Voriconazole | 2014 |
Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort.
Topics: Adult; Aged; Antifungal Agents; Aspergillus; Brain; Cohort Studies; Critical Illness; Female; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Neuroaspergillosis; Pyrimidines; Risk Factors; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2014 |
[Caspofungin and voriconazole combination therapy for invasive pulmonary aspergillosis in patients with liver failure: a report of two cases].
Topics: Caspofungin; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Liver Failure; Male; Middle Aged; Voriconazole | 2014 |
Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients.
Topics: Aged; Antifungal Agents; Bilirubin; Blood Proteins; Chromatography, Liquid; Critical Illness; Female; Humans; Hypoalbuminemia; Intensive Care Units; Invasive Pulmonary Aspergillosis; Liver Function Tests; Male; Middle Aged; Prospective Studies; Protein Binding; Serum Albumin; Tandem Mass Spectrometry; Voriconazole | 2014 |
Invasive pulmonary aspergillosis: a rare complication after microwave ablation.
Topics: Ablation Techniques; Adenocarcinoma; Aged; Antifungal Agents; Carcinoma, Squamous Cell; Female; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung Neoplasms; Male; Microwaves; Middle Aged; Voriconazole | 2014 |
Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Caspofungin; Child; Drug Therapy, Combination; Echinocandins; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult | 2015 |
[Mixed types of pulmonary aspergillosis].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Glucocorticoids; Humans; Invasive Pulmonary Aspergillosis; Pulmonary Aspergillosis; Retrospective Studies; Voriconazole | 2014 |
Immune reconstitution inflammatory syndrome in neutropenic patients with invasive pulmonary aspergillosis.
Topics: Antifungal Agents; Female; Galactose; Humans; Immune Reconstitution Inflammatory Syndrome; Invasive Pulmonary Aspergillosis; Lung; Male; Mannans; Middle Aged; Neutropenia; Republic of Korea; Retrospective Studies; Voriconazole | 2015 |
Posaconazole liquid suspension in solid organ transplant recipients previously treated with voriconazole.
Topics: Antifungal Agents; Female; Hematopoietic Stem Cell Transplantation; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Mycoses; Transplant Recipients; Transplants; Triazoles; Voriconazole | 2015 |
Autoinduction of voriconazole metabolism in a child with invasive pulmonary aspergillosis.
Topics: Anemia, Aplastic; Antifungal Agents; Antineoplastic Agents, Alkylating; Child; Cyclophosphamide; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Voriconazole | 2015 |
Chronic necrotizing pulmonary aspergillosis in a patient with diabetes and marijuana use.
Topics: Adult; Antifungal Agents; Cannabis; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Empyema, Pleural; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Marijuana Smoking; Medical Marijuana; Pneumothorax; Radiography; Volatilization; Voriconazole | 2015 |
Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France.
Topics: Adult; Anti-HIV Agents; Antifungal Agents; Aspergillosis; Aspergillus; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; France; HIV Infections; Humans; Invasive Pulmonary Aspergillosis; Male; Medical Records; Middle Aged; Proportional Hazards Models; Survival Rate; Time Factors; Voriconazole | 2015 |
Rare Case: Invasive Pseudomembranous Aspergillus Tracheobronchitis in a Postpartum Patient Presenting With Stridor.
Topics: Adult; Antifungal Agents; Aspergillus; Biopsy; Bronchitis; Bronchoscopy; Female; Humans; Invasive Pulmonary Aspergillosis; Lung Diseases, Fungal; Postpartum Period; Rare Diseases; Respiratory Sounds; Tracheitis; Voriconazole | 2015 |
Successful Treatment of Combined Aspergillus and Cytomegalovirus Abscess in Brain and Lung After Liver Transplant for Toxic Fulminant Hepatitis.
Topics: Antifungal Agents; Biopsy; Brain Abscess; Chemical and Drug Induced Liver Injury; Cytomegalovirus Infections; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Liver Transplantation; Lung Abscess; Magnetic Resonance Imaging; Middle Aged; Mushroom Poisoning; Neuroaspergillosis; Neurosurgical Procedures; Opportunistic Infections; Tomography, X-Ray Computed; Treatment Outcome; Voriconazole | 2017 |
Chronic pulmonary aspergillosis: help is on the way.
Topics: Antifungal Agents; Chronic Disease; Hemoptysis; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Practice Guidelines as Topic; Pulmonary Aspergillosis; Voriconazole | 2016 |
Invasive aspergillosis in a paediatric allogeneic stem cell transplantation recipient owing to a susceptible Aspergillus fumigatus: Treatment failure with high doses of voriconazole and influence of CYP2C19 polymorphisms.
Topics: Antifungal Agents; Aspergillus fumigatus; Child, Preschool; Cytochrome P-450 CYP2C19; Humans; Invasive Pulmonary Aspergillosis; Male; Polymorphism, Genetic; Stem Cell Transplantation; Transplant Recipients; Transplantation, Homologous; Treatment Failure; Voriconazole | 2016 |
Invasive Aspergillus infection requiring lobectomy in a CYP2C19 rapid metabolizer with subtherapeutic voriconazole concentrations.
Topics: Antifungal Agents; Child; Cytochrome P-450 CYP2C19; Drug Monitoring; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Pharmacogenomic Variants; Precision Medicine; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Voriconazole | 2016 |
Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Drug Resistance, Fungal; Female; Humans; Incidence; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prevalence; Retrospective Studies; Survival Analysis; Voriconazole | 2017 |
Genotyping of Aspergillus fumigatus Reveals Compartmentalization of Genotypes in Disseminated Disease after Invasive Pulmonary Aspergillosis.
Topics: Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillus fumigatus; Female; Genotype; Graft vs Host Disease; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Microbial Sensitivity Tests; Microsatellite Repeats; Molecular Typing; Mycological Typing Techniques; Triazoles; Voriconazole | 2017 |
Pulmonary infiltrate with characteristic "reversed halo" and "air crescent" signs.
Topics: Antifungal Agents; Aspergillus; Astrocytoma; Bronchoscopy; Combined Modality Therapy; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pancytopenia; Tomography, X-Ray Computed; Voriconazole | 2017 |
Invasive pulmonary aspergillosis after near-drowning.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fatal Outcome; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Near Drowning; Shock, Septic; Voriconazole | 2016 |
Uptake and efflux kinetics, and intracellular activity of voriconazole against Aspergillus fumigatus in human pulmonary epithelial cells: a new application for the prophylaxis and early treatment of invasive pulmonary aspergillosis.
Topics: A549 Cells; Antibiotic Prophylaxis; Antifungal Agents; Aspergillus fumigatus; Cell Line, Tumor; Epithelial Cells; Half-Life; Humans; Invasive Pulmonary Aspergillosis; Kinetics; Lung; Voriconazole | 2017 |
Subacute invasive pulmonary aspergillosis as a rare cause of pneumothorax in immunocompetent patient: brief report.
Topics: Antifungal Agents; Aspergillus fumigatus; Female; Humans; Immunocompetence; Invasive Pulmonary Aspergillosis; Middle Aged; Pneumothorax; Treatment Outcome; Voriconazole | 2017 |
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin.
Topics: Anidulafungin; Animals; Antifungal Agents; Area Under Curve; Aspergillus fumigatus; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Neutropenia; Pyrimidines; Rats; Treatment Outcome; Triazoles; Voriconazole | 2009 |
[Invasive pulmonary aspergillosis. Occurrence in a non-neutropenic female patient with abdominal sepsis].
Topics: Abdomen; Antifungal Agents; Caspofungin; Colonic Neoplasms; Critical Illness; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Laparotomy; Lipopeptides; Middle Aged; Peritonitis; Physical Therapy Modalities; Postoperative Complications; Pyrimidines; Sepsis; Triazoles; Voriconazole | 2009 |
Dose tolerability of chronically inhaled voriconazole solution in rodents.
Topics: Administration, Inhalation; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Delivery Systems; Female; Invasive Pulmonary Aspergillosis; Lung; Macrophages, Alveolar; Male; Pyrimidines; Rats; Rats, Sprague-Dawley; Tissue Distribution; Triazoles; Voriconazole | 2009 |
Designing a treatment protocol with voriconazole to eliminate Aspergillus fumigatus from experimentally inoculated pigeons.
Topics: Administration, Inhalation; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bird Diseases; Columbidae; Invasive Pulmonary Aspergillosis; Liver; Pyrimidines; Triazoles; Voriconazole | 2009 |
Concomitant Aspergillus and Cytomegalovirus infection in heart transplant: early diagnosis is the key to successful treatment.
Topics: Acute Disease; Antifungal Agents; Antiviral Agents; Cardiomyopathy, Dilated; Cytomegalovirus Infections; Early Diagnosis; Ganciclovir; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Opportunistic Infections; Pulse Therapy, Drug; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2009 |
Successful voriconazole treatment of invasive pulmonary aspergillosis in a patient with acute biphenotypic leukemia.
Topics: Adult; Antifungal Agents; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Biphenotypic, Acute; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2009 |
Pseudomembranous Aspergillus tracheobronchitis in a heart transplant recipient.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Bronchitis; Bronchoscopy; Female; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Middle Aged; Pyrimidines; Tracheitis; Triazoles; Voriconazole | 2010 |
Defining fractional inhibitory concentration index cutoffs for additive interactions based on self-drug additive combinations, Monte Carlo simulation analysis, and in vitro-in vivo correlation data for antifungal drug combinations against Aspergillus fumi
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Colorimetry; Confidence Intervals; Drug Therapy, Combination; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Monte Carlo Method; Pyrimidines; Triazoles; Voriconazole | 2010 |
Prophylaxis of invasive aspergillosis with voriconazole or caspofungin during building work in patients with acute leukemia.
Topics: Adolescent; Adult; Aged; Air Pollutants; Caspofungin; Cohort Studies; Construction Materials; Echinocandins; Female; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole; Young Adult | 2010 |
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Topics: Adolescent; Adult; Antifungal Agents; Aspergillus; Caspofungin; Cystic Fibrosis; Drug Interactions; Drug Therapy, Combination; Echinocandins; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Middle Aged; Pyrimidines; Retrospective Studies; Tacrolimus; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2010 |
Successful allogeneic stem cell transplantation in two patients with acute myelogenous leukaemia and invasive aspergillosis by antifungal combination therapy.
Topics: Amphotericin B; Antifungal Agents; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Lipopeptides; Micafungin; Middle Aged; Pyrimidines; Stem Cell Transplantation; Transplantation, Homologous; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adult; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Asthma; Bronchoscopy; Caspofungin; Chronic Disease; Drug Therapy, Combination; Echinocandins; Female; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Prognosis; Pyrimidines; Radiography, Thoracic; Recurrence; Risk Assessment; Severity of Illness Index; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2008 |
Hospital costs and outcomes among intravenous antifungal therapies for patients with invasive aspergillosis in the United States.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Cohort Studies; Echinocandins; Female; Hospital Costs; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Length of Stay; Lipopeptides; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; United States; Voriconazole | 2011 |
Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Topics: Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillus fumigatus; Biomarkers; Biopsy; Bronchoalveolar Lavage Fluid; Female; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Mannans; Middle Aged; Postoperative Complications; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Triazoles; Voriconazole | 2011 |
Treatment of invasive aspergillosis with nonmyeloablative allogeneic stem cell transplantation: one stone two birds.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Humans; Immunosuppression Therapy; Invasive Pulmonary Aspergillosis; Leukemia; Pyrimidines; Radiography; Remission Induction; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Triazoles; Voriconazole | 2011 |
Bipolaris hawaiiensis as etiologic agent of allergic bronchopulmonary mycosis: first case in a paediatric patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Aspergillus fumigatus; beta-Glucans; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Female; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Itraconazole; Microbial Sensitivity Tests; Microscopy; Molecular Sequence Data; Mycological Typing Techniques; Phylogeny; Prednisone; Pyrimidines; Sequence Analysis, DNA; Sputum; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Deoxycholic Acid; Disease Models, Animal; Drug Combinations; Drug Therapy, Combination; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Mice; Mice, Inbred DBA; Pyrimidines; Triazoles; Voriconazole | 2011 |
An accidental mass.
Topics: Accidents, Traffic; Adult; Aspergillus flavus; Caspofungin; Combined Modality Therapy; Coronary Thrombosis; Diagnosis, Differential; Disease Progression; Echinocandins; Echocardiography; Echocardiography, Transesophageal; Embolism; Emergency Service, Hospital; Endocarditis; Female; Fractures, Bone; Humans; Incidental Findings; Invasive Pulmonary Aspergillosis; Lipopeptides; Mediastinal Diseases; Pelvic Bones; Pyrimidines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Resolution of galactomannan antigenemia in a patient receiving oral voriconazole for chronic necrotizing pulmonary aspergillosis.
Topics: Antifungal Agents; Antigens, Fungal; Drug Monitoring; Galactose; Humans; Invasive Pulmonary Aspergillosis; Male; Mannans; Pyrimidines; Triazoles; Voriconazole; Young Adult | 2011 |
A case of pseudomembranous colitis after voriconazole therapy.
Topics: Adult; Antifungal Agents; Enterocolitis, Pseudomembranous; Humans; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole | 2011 |
Aspergillus fumigatus spondylodiskitis in renal transplant patient: voriconazole experience.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus fumigatus; Back Pain; Discitis; Diskectomy; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Kidney Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Pyrimidines; Treatment Outcome; Triazoles; Tuberculosis, Pulmonary; Voriconazole | 2011 |
Combination antifungal therapy for invasive pulmonary aspergillosis in a heart transplant recipient.
Topics: Antifungal Agents; Drug Therapy, Combination; Echinocandins; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Micafungin; Middle Aged; Pyrimidines; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Incidence; Infant; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Risk Factors; Survival Analysis; Taiwan; Triazoles; Voriconazole; Young Adult | 2012 |
Fatal pandemic influenza A/H1N1 infection complicated by probable invasive pulmonary aspergillosis.
Topics: Aged; Antifungal Agents; Antiviral Agents; Fatal Outcome; Humans; Immunocompetence; Influenza A Virus, H1N1 Subtype; Influenza, Human; Invasive Pulmonary Aspergillosis; Male; Oseltamivir; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive pulmonary aspergillosis in non-neutropenic patients: analysis of a 14-month prospective clinical experience.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Comorbidity; Early Diagnosis; Female; Galactose; Hospital Units; Hospitals, University; Humans; Invasive Pulmonary Aspergillosis; Italy; Leukocyte Count; Male; Mannans; Middle Aged; Prospective Studies; Pyrimidines; Triazoles; Voriconazole | 2011 |
Invasive pulmonary aspergillosis in a patient with seminomatous testicular cancer.
Topics: Adult; Antifungal Agents; Antineoplastic Agents; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Pyrimidines; Testicular Neoplasms; Treatment Outcome; Triazoles; Voriconazole | 2011 |
[Invasive aspergillosis: new tools for a targeted medical management].
Topics: Adult; Aged; Antifungal Agents; Antigens, Fungal; Aspergillosis; beta-Glucans; Clinical Trials as Topic; Comorbidity; Disease Management; Female; France; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Prospective Studies; Pyrimidines; Risk Factors; Survival Rate; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Chronic granulomatous disease in an adult recognized by an invasive aspergillosis.
Topics: Antifungal Agents; Aspergillus; Diagnosis, Differential; Germany; Granulomatous Disease, Chronic; Humans; Infusions, Parenteral; Invasive Pulmonary Aspergillosis; Itraconazole; Lung; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Phagocytes; Pyrimidines; Respiratory Insufficiency; Tachypnea; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Prophylactic efficacy of single dose pulmonary administration of amphotericin B inhalation powder in a guinea pig model of invasive pulmonary aspergillosis.
Topics: Administration, Inhalation; Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Chemoprevention; Colony Count, Microbial; Cortisone; Cyclophosphamide; Disease Models, Animal; Guinea Pigs; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Lung; Male; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2012 |
Therapeutic monitoring of voriconazole in children less than three years of age: a case report and summary of voriconazole concentrations for ten children.
Topics: Antifungal Agents; Child, Preschool; Drug Monitoring; Female; Humans; Infant; Invasive Pulmonary Aspergillosis; Male; Plasma; Pyrimidines; Triazoles; Voriconazole | 2012 |
Invasive aspergillosis in pediatric oncology patients: a rare event with poor prognosis--case analysis to plan better targeted prophylactic or therapeutic measurement.
Topics: Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cell Transplantation; Humans; Infusions, Intravenous; Invasive Pulmonary Aspergillosis; Leukemia, Myeloid, Acute; Male; Opportunistic Infections; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Pyrimidines; Retrospective Studies; Survival Rate; Triazoles; Voriconazole | 2012 |
[Ambulatory therapy of aspergillosis in hematological and oncological patients].
Topics: Ambulatory Care; Antifungal Agents; Caspofungin; Echinocandins; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Itraconazole; Lipopeptides; Neutropenia; Pyrimidines; Salvage Therapy; Triazoles; Voriconazole | 2012 |
Comparison of serum and bronchoalveolar lavage galactomannan in diagnosing invasive aspergillosis in solid-organ transplant recipients.
Topics: Adult; Antifungal Agents; Biomarkers; Bronchoalveolar Lavage Fluid; Caspofungin; Drug Therapy, Combination; Echinocandins; Galactose; Heart Transplantation; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Lung Transplantation; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Pyrimidines; Retrospective Studies; Sensitivity and Specificity; Transplantation; Triazoles; Voriconazole | 2012 |
Pharmacodynamics of voriconazole in a dynamic in vitro model of invasive pulmonary aspergillosis: implications for in vitro susceptibility breakpoints.
Topics: Antifungal Agents; Aspergillus fumigatus; Bioreactors; Cell Culture Techniques; Cells, Cultured; Chromatography, High Pressure Liquid; Computer Simulation; Decision Support Techniques; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Fungal; Endothelial Cells; Epithelial Cells; Galactose; Humans; Invasive Pulmonary Aspergillosis; Mannans; Microbial Sensitivity Tests; Models, Biological; Pulmonary Artery; Pyrimidines; Respiratory Mucosa; Triazoles; Voriconazole | 2012 |
Initial voriconazole trough blood levels and clinical outcomes of invasive aspergillosis in patients with hematologic malignancies.
Topics: Adult; Aged; Antifungal Agents; Female; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Republic of Korea; Tertiary Care Centers; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Combination of voriconazole and anidulafungin for treatment of triazole-resistant aspergillus fumigatus in an in vitro model of invasive pulmonary aspergillosis.
Topics: Anidulafungin; Antifungal Agents; Aspergillus fumigatus; Cell Line; Chromatography, High Pressure Liquid; Drug Interactions; Echinocandins; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Models, Theoretical; Pulmonary Alveoli; Pyrimidines; Triazoles; Voriconazole | 2012 |
Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Debridement; Drug Therapy, Combination; Heart Transplantation; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Pyrimidines; Sinusitis; Treatment Outcome; Triazoles; Voriconazole; Zygomycosis | 2012 |
[The importance of bronchoalveolar lavage sample for galactomannan, 1,3-ß-d-glucan and PCR tests].
Topics: Antifungal Agents; beta-Glucans; Bronchoalveolar Lavage Fluid; Bronchoscopy; Child; Cystic Fibrosis; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lymphoma, Large B-Cell, Diffuse; Male; Mannans; Pyrimidines; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2012 |
Invasive pulmonary aspergillosis in patients with acute-on-chronic liver failure.
Topics: Adult; Aged; Anti-Bacterial Agents; Antifungal Agents; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Invasive Pulmonary Aspergillosis; Liver Failure, Acute; Male; Middle Aged; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Combination antifungal therapy for invasive pulmonary aspergillosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Invasive Pulmonary Aspergillosis; Lymphoma, Non-Hodgkin; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Concurrent pulmonary Aspergillus fumigatus and mucor infection in a cardiac transplant recipient: a case report.
Topics: Air Microbiology; Antifungal Agents; Cardiomyopathy, Dilated; Cyclonic Storms; Environmental Exposure; Heart Transplantation; Humans; Immunosuppressive Agents; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Mucormycosis; Pyrimidines; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2013 |
Invasive pulmonary aspergillosis due to Emericella nidulans var. echinulata, successfully cured by voriconazole and micafungin.
Topics: Aged; Antifungal Agents; DNA, Fungal; Echinocandins; Emericella; Exudates and Transudates; Galactose; Glucocorticoids; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Microscopy; Molecular Sequence Data; Pyrimidines; Sequence Analysis, DNA; Treatment Outcome; Triazoles; Voriconazole | 2013 |